Two senior management appointments: Mr. Laxmikant Tiwari and Mr. Nilesh Vartak appointed effective 12th October 2026
Alkem Laboratories has appointed Mr. Laxmikant Tiwari and Mr. Nilesh Vartak at senior management positions in the Company, effective 12th October 2026.
- Date of Appointment
- 12th October 2026
- Appointee Experience
- Mr. Laxmikant Tiwari - 27+ years of experience
- Appointee Experience
- Mr. Nilesh Vartak - over 24 years of experience in supply chain leadership
Alkem Laboratories has informed the stock exchanges about two appointments at senior management positions in the Company, both effective from 12th October 2026. The intimation was made under Regulation 30 of the SEBI LODR Regulations, and the required particulars were provided in an annexure to the letter.
Who has been appointed
- Mr. Laxmikant Tiwari
- Mr. Nilesh Vartak
Both are shown in the annexure as appointed at senior management positions, with the same effective date of 12th October 2026.
What the annexure states about each appointment
- Reason for change: Appointment
- Date of appointment: 12th October 2026
- Term of Appointment: duration of the contract shall be so long as he is in employment of the Company
- Disclosure of relationships between directors: Not Applicable
The same terms are shown for both individuals.
Brief profiles shared
- Mr. Laxmikant Tiwari is described as an experienced pharmaceutical operations executive with 27+ years of experience. He holds an MBA in Operations Management and a Bachelors degree in Pharmacy.
- Mr. Nilesh Vartak is described as having over 24 years of experience in supply chain leadership across the pharmaceutical/healthcare and consumer goods sectors. He holds an MBA in Finance and a Bachelors degree in Marine Engineering.
How to read this
A change-in-management disclosure tells shareholders who is taking on senior management responsibility in the company. The profiles shared show the professional background and years of experience each appointee brings, which is the main information a reader can weigh here. The company has also said the information is available on its website.
What a reader can check
- The names of the two appointees
- Their effective date of appointment
- Their stated experience and qualifications
- The stated term of the appointment
Also from Alkem Laboratories
Brokerage Amquity upgraded Alkem Laboratories to outperform from underperform and raised target price to 6,000 from 4,900
7 Oct 2026
CFO Nitin Agrawal Resigns, To Be Relieved From 30 September 2026
24 Sep 2026
More numbers
- Experience of Mr. Laxmikant Tiwari27+ years
- Experience of Mr. Nilesh Vartakover 24 years
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.